Detalhe da pesquisa
1.
N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial.
J Neuroinflammation
; 20(1): 209, 2023 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705084
2.
N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation.
J Biol Chem
; 295(51): 17413-17424, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33453988
3.
Age-associated impairment of T cell immunity is linked to sex-dimorphic elevation of N-glycan branching.
Nat Aging
; 2(3): 231-242, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35528547
4.
Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration.
JAMA Neurol
; 78(7): 842-852, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33970182
5.
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
J Neuroimmunol
; 256(1-2): 71-6, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23351704
6.
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation.
Semin Immunopathol
; 34(3): 415-24, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22488447